Bank of America
BAC
$52.48
+1.88%
Bank of America Corporation is a leading diversified financial services institution operating globally, with core businesses spanning consumer banking, global wealth and investment management, global banking, and global markets. As the second-largest deposit holder in the United States with a formidable $3.5 trillion balance sheet, it is a dominant market leader and a cornerstone of the American financial system. The current investor narrative is heavily influenced by the potential for a major portfolio shift, as Berkshire Hathaway's new leadership appears poised to fully exit its massive stake, alongside ongoing debates about the impact of persistently high interest rates on net interest margins and credit quality.…
BAC
Bank of America
$52.48
Related headlines
Investment Opinion: Should I buy BAC Today?
Rating & Thesis: Hold. BAC is a fundamentally sound but sentiment-challenged mega-cap bank caught between attractive valuation and significant near-term overhangs, making it unsuitable for new capital allocation until the technical picture improves. The minimal analyst coverage provides no strong consensus to anchor against.
Supporting Evidence: The primary valuation metric, the trailing PE of 13.28x, sits at the lower end of its 2-year historical range, suggesting a discount. The PEG ratio of 0.68 signals undervaluation relative to growth. Profitability is robust with a net margin of 15.15% and ROE of 10.06%. However, these strengths are counteracted by a -7.77% YTD return and a severe -8.73% one-month relative strength reading, indicating powerful selling pressure.
Risks & Conditions: The two biggest risks are the potential Berkshire Hathaway exit and continued sector underperformance. This Hold rating would upgrade to a Buy if the stock stabilizes above its 200-day moving average (signaling technical repair) and the Berkshire overhang is resolved, or if the forward PE compresses further towards 9x. It would downgrade to a Sell if the price breaks decisively below the $48 support level (recent lows) or if quarterly revenue growth turns negative. The stock is fairly valued to slightly undervalued on fundamentals but is overvalued in the context of its negative momentum and sentiment.
Sign up to view all
BAC 12-Month Price Forecast
The outlook is neutral with a bias towards cautious optimism over the long term, but near-term headwinds are significant. The stock's compelling fundamental valuation (low PE, high FCF) is currently being overshadowed by technical damage and a major sentiment overhang. The base case of range-bound consolidation is most likely, as the company's financial fortress should prevent a meltdown, but the lack of positive catalysts and sector weakness will cap rallies. The stance would upgrade to bullish on a confirmed technical reversal above $55 or a clear resolution of the Berkshire selling pressure. It would turn bearish on a breakdown below $48, which would signal the bear case is unfolding.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bank of America's 12-month outlook, with a consensus price target around $68.22 and implied upside of +30.0% versus the current price.
Average Target
$68.22
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$42 - $68
Analyst target range
Insufficient analyst coverage available. The provided data shows only 2 analysts contributing to estimates, which is minimal for a company of Bank of America's size and market capitalization. This limited coverage can lead to higher volatility and less efficient price discovery, as there are fewer informed opinions shaping market consensus. It may also indicate that the stock is receiving less scrutiny from the sell-side, potentially because it is perceived as a stable, well-understood mega-cap within a cyclical sector. The wide target range implied by the EPS estimates (low: $6.75, high: $6.94, avg: $6.82) is relatively tight, but with so few data points, it does not convey meaningful market sentiment. Investors should rely more heavily on independent fundamental and macro analysis for this stock.
Bulls vs Bears: BAC Investment Factors
The evidence presents a classic battle between strong fundamentals and weak price momentum. The bull case is anchored in solid profitability, attractive valuation (PEG of 0.68, PE near historical lows), and robust cash generation. The bear case is driven by severe technical underperformance, a looming major shareholder exit, and high macro sensitivity. Currently, the bearish technical and sentiment factors appear to have the upper hand, as evidenced by the stock's persistent underperformance despite sound financials. The single most important tension in the investment debate is the resolution of the Berkshire Hathaway overhang; if the exit is managed orderly, the strong fundamentals could reassert themselves, but a disorderly sell-off could prolong the technical weakness.
Bullish
- Strong Profitability & Margin Expansion: Q4 2025 net income of $7.53 billion represents a 12.9% YoY increase from $6.67 billion, with the net margin expanding from 14.19% to 15.15%. This demonstrates effective cost management and operational leverage as revenue grows.
- Undervalued PEG Ratio: The PEG ratio of 0.68, based on a trailing PE of 13.28x, indicates the stock is undervalued relative to its earnings growth rate. This is a classic value signal, suggesting the market is not fully pricing in future earnings potential.
- Robust Free Cash Flow Generation: The company generated $12.61 billion in trailing twelve-month free cash flow, providing ample internal capital for shareholder returns and strategic investments. This financial strength underpins the 2.36% dividend yield and supports buybacks.
- Historical Valuation at Lower End: The current trailing PE of 13.28x sits near the lower end of its own 2-year historical range, which has seen peaks above 21x. This suggests the stock is priced conservatively, offering a margin of safety if fundamentals remain stable.
Bearish
- Severe Relative Underperformance: The stock has a -8.73% relative strength vs. the S&P 500 over the past month and is down -7.77% YTD, significantly lagging the broader market's 10.93% YTD gain. This indicates strong sector-specific and stock-specific headwinds.
- Potential Berkshire Hathaway Exit: Recent news indicates Berkshire Hathaway's new leadership appears poised to fully exit its massive BAC stake. This represents a significant overhang, as a large, sustained sell-off from a major investor could pressure the stock price.
- High Sensitivity to Market Volatility: With a beta of 1.221, BAC is approximately 22% more volatile than the S&P 500. This high sensitivity to market and interest rate swings makes the stock riskier than typical large-cap peers, especially in a volatile macro environment.
- Decelerating Revenue Growth: Year-over-year revenue growth has decelerated to 5.8% in Q4 2025. While sequential growth is positive, the slowing pace raises questions about the sustainability of top-line expansion, particularly in a potentially peaking interest rate cycle.
BAC Technical Analysis
The stock is in a sustained downtrend from its recent highs, trading at $51.60, which is approximately 89.6% of its 52-week range (52-week high: $57.55, 52-week low: $43.36). Despite a positive 1-year price change of 16.64%, the stock has declined -7.77% year-to-date and -3.82% over the last six months, indicating a significant loss of momentum and positioning it closer to the middle of its annual range, suggesting a period of consolidation after a strong prior-year rally. Recent short-term momentum is negative and diverging from the longer-term trend, with the stock down -2.42% over the past month, which contrasts sharply with the S&P 500's gain of 6.31% over the same period, resulting in a severe relative strength reading of -8.73. This divergence signals significant underperformance and potential sector-specific headwinds, as the 3-month price change of 3.55% also lags the broader market's 10.28% gain. Key technical support is anchored at the 52-week low of $43.36, while immediate resistance sits at the 52-week high of $57.55; a sustained breakdown below the $50 level could accelerate a test of the 52-week low, whereas a breakout above $57.55 would signal a resumption of the prior uptrend. With a beta of 1.221, the stock is approximately 22% more volatile than the S&P 500, which is significant for a large-cap bank and implies greater sensitivity to market swings and interest rate fluctuations, necessitating larger position-sizing adjustments for risk management.
Beta
1.22
1.22x market volatility
Max Drawdown
-18.4%
Largest decline past year
52-Week Range
$44-$58
Price range past year
Annual Return
+19.1%
Cumulative gain past year
| Period | BAC Return | S&P 500 |
|---|---|---|
| 1m | -1.4% | +5.4% |
| 3m | +4.3% | +10.9% |
| 6m | -3.1% | +11.0% |
| 1y | +19.1% | +28.1% |
| ytd | -6.2% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAC Fundamental Analysis
Revenue growth has been positive but decelerating, with Q4 2025 revenue of $49.69 billion representing a 5.8% year-over-year increase; however, examining the quarterly sequence from Q1 2025 ($46.99B) to Q4 2025 ($49.69B) shows a trend of sequential growth, though the pace moderated from the high single-digit YoY growth seen in earlier 2025 quarters. Segment data indicates the Consumer Banking segment generated the largest revenue at $10.81 billion in the latest period, followed by Global Markets at $5.98 billion, suggesting these are primary growth drivers. The company is solidly profitable, with Q4 2025 net income of $7.53 billion and a net margin of 15.15%; gross margin for the quarter was strong at 60.12%, and the trailing operating margin is 19.68%. Profitability has shown improvement year-over-year, as Q4 2024 net income was $6.67 billion with a net margin of 14.19%, indicating margin expansion driven by revenue growth and potentially effective cost management. The balance sheet is robust with a debt-to-equity ratio of 1.21, indicating a moderate level of leverage typical for a large bank, and a return on equity of 10.06%, which is a solid level of profitability for shareholders. Free cash flow over the trailing twelve months is a healthy $12.61 billion, providing ample internal funding for dividends, share buybacks, and organic growth, while the current ratio of 0.42 reflects the standard banking model of holding substantial non-cash assets and is not a direct liquidity concern for a deposit-taking institution.
Quarterly Revenue
$49.7B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.60%
Latest Quarter
Free Cash Flow
$12.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAC Overvalued?
Given a positive net income of $7.53 billion, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 13.28x, while the forward PE is 10.22x, based on estimated EPS; the forward multiple being lower suggests the market anticipates earnings growth, with the gap implying an expected earnings increase of approximately 30% if the price holds steady. Compared to sector averages, the stock's trailing PE of 13.28x and Price-to-Sales (PS) ratio of 2.11x are not directly comparable without explicit industry averages in the data, but the forward PE of 10.22x appears reasonable for a large, stable financial institution, especially when considering its PEG ratio of 0.68, which indicates the stock may be undervalued relative to its earnings growth rate. Historically, the current trailing PE of 13.28x sits below its own 2-year historical range observed in the data, which has seen peaks above 21x in late 2023 and lows around 7x in 2023; this positioning near the lower end of its recent historical band suggests the market is pricing in conservative expectations, potentially offering a value opportunity if the fundamental outlook stabilizes or improves.
PE
13.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 7x~21x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: BAC faces margin pressure risks from a potential shift in the interest rate cycle, as net interest income, a key revenue driver, could compress if rates decline. While the debt-to-equity ratio of 1.21 is moderate for a bank, the high beta of 1.221 indicates earnings and the stock price are highly sensitive to economic cycles and credit quality trends. Revenue concentration in interest-sensitive businesses (Consumer Banking, Global Markets) exposes the company to cyclical downturns, though sequential revenue growth to $49.69B in Q4 2025 shows current resilience.
Market & Competitive Risks: The stock trades at a forward PE of 10.22x, which appears reasonable but is vulnerable to multiple compression if the sector falls out of favor, as seen in its significant underperformance versus the S&P 500. Competitive risks are heightened as peers like Wells Fargo show operational comebacks, potentially pressuring BAC's market share. Macro risks are pronounced, with news highlighting 30-year Treasury yields at 5%, which pressures equity valuations and increases the cost of capital for the entire banking sector.
Worst-Case Scenario: The most damaging scenario involves a disorderly exit by Berkshire Hathaway coinciding with a recession that triggers rising loan losses and collapsing net interest margins. This could lead to a severe derating of the stock towards its 52-week low of $43.36. From the current price of $51.60, this represents a realistic downside of approximately -16%. A breach of that level could see the stock test lower supports, potentially matching the -18.39% max drawdown observed in the data, leading to total losses approaching -20% to -25% in an extended adverse period.
FAQ
The key risks are, in order of severity: 1) Shareholder Overhang: The potential for a massive, sustained sell-off by Berkshire Hathaway, creating persistent selling pressure. 2) Macro & Interest Rate Sensitivity: With a beta of 1.221, the stock is highly volatile and exposed to economic cycles and shifts in Fed policy that impact net interest margins. 3) Sector Underperformance: Financials have severely lagged the market, as shown by BAC's -18.7% YTD relative strength, and this trend could continue. 4) Growth Deceleration: YoY revenue growth has slowed to 5.8%, raising sustainability concerns.
Our 12-month forecast outlines three scenarios. The Base Case (60% probability) sees the stock trading between $50 and $57.55, consolidating within its annual range as it digests overhangs. The Bull Case (25% probability) targets $57.55 to $62, driven by a smooth Berkshire exit and improving sector sentiment. The Bear Case (15% probability) risks a drop to the $43.36 - $48 range if selling accelerates amid a downturn. The Base Case is most likely, implying limited near-term upside from the current ~$51.60 price, with the key assumption being a managed resolution of the major shareholder exit.
BAC appears fairly valued to slightly undervalued based on fundamental metrics. Its trailing PE of 13.28x is near the lower end of its 2-year historical range, and its PEG ratio of 0.68 is a clear signal of undervaluation relative to earnings growth. However, the market is currently applying a discount due to non-fundamental factors like the Berkshire overhang and sector rotation. Therefore, the stock is fundamentally undervalued but fairly or even overvalued in the context of its negative momentum and near-term sentiment risks.
BAC is not a compelling buy at the current moment for most investors. While its fundamentals are strong with a 15.15% net margin and an attractive PEG ratio of 0.68, the stock is plagued by severe technical underperformance (-8.73% vs. S&P 500 over 1 month) and a major overhang from Berkshire Hathaway's potential full exit. It could be a good buy for very patient, value-focused investors willing to wait 2-3 years for sentiment to improve, but those looking for near-term outperformance should wait for the technical picture to stabilize, ideally above the $55 level.
BAC is suitable only for a long-term investment horizon of 3-5 years. Its high beta of 1.221 and current negative momentum make it a poor candidate for short-term trading. As a cyclical, dividend-paying value stock, its thesis requires time for sentiment to reverse and for its fundamental undervaluation (PEG 0.68) to be recognized by the market. The 2.36% dividend yield provides some income while waiting. Investors should be prepared to hold through potential further volatility, especially related to the Berkshire Hathaway divestment.
